FCS Leaders Serve on 2021 Faculty for Value-Based Cancer Care Summit

Fort Myers, Fla., Sep, 2021 – Senior leaders of Florida Cancer Specialists & Research Institute (FCS) have been invited to serve on the faculty for the Association for Value-Based Cancer Care 2021 Summit & Educational Program being held in New York, NY on Oct. 13 – 15.  The three-day, invitation-only forum will bring together medical experts and influential leaders from across the country to share insights and best practice strategies that focus on clinical, cost and access issues designed to maximize value in cancer care.  

Participating on the diverse panel of expert practitioners, pharmacists, payers, policymakers, and other key stakeholders are:

• FCS Chief Executive Officer Nathan H. Walcker – panelist, Value-Based Programs: What Worked, What Failed and What is Needed
• FCS Assistant Managing Physician Michael Diaz, MD – panelist, AI and Decision Support and panelist, Migrating from OCM and Preparing for Next-Generation Alternative Payment Programs
• FCS Senior Vice President of Pharmacy Services Ray Bailey, BPharm, RPH – panelist,  Integrated Oncology Pharmacy

“FCS has been on the forefront of the transition of oncology care reimbursement to methodologies that are based on quality and value, and we consistently outpace industry targets and benchmarks,” said FCS CEO Nathan H. Walcker.  “At the AVBCC Summit we will join with colleagues from every facet of the cancer care ecosystem who are equally committed to further maximizing value in oncology care.”

FCS President & Managing Physician Dr. Lucio Gordan said, “We are proud to participate and will take full advantage of this opportunity to share leading-edge initiatives that impact quality and cost, with the ultimate goal of ensuring that optimal care is delivered to patients with cancer.”

###

About Florida Cancer Specialists & Research Institute
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. Over the past 5 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, MD Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.

Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies, and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians, and staff.

*Prior to approval